Condensed Statement of Cash Flows (Unaudited)	4 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (125,414)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(32,984)
Unrealized loss on securities held in Trust Account	8,375
Deferred income tax benefit	(1,759)
Prepaid expenses	(168,847)
Accrued expenses	31,666
Net cash used in operating activities	(288,963)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(319,453,440)
Net cash used in investing activities	(319,453,440)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	313,064,371
Proceeds from sale of Private Placement Warrants	8,139,069
Due to Sponsor	510,914
Proceeds from promissory note - related party	142,931
Repayment of promissory note - related party	(142,931)
Payment of offering costs	(431,681)
Net cash provided by financing activities	321,282,673
Net Change in Cash	1,540,270
Cash — Beginning
Cash — Ending	1,540,270
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	304,589,870
Change in value of common stock subject to possible redemption	(124,401)
Deferred underwriting fee payable	11,180,870
Offering costs paid directly by Sponsor in exchange for the issuance of common stock	$ 25,000